Archive | Conferences

Neoadjuvant T-VEC May Reduce Recurrence in Operable Melanoma

Source: OncLive, July 2019 Neoadjuvant treatment with the oncolytic immunotherapeutic agent talimogene laherparepvec (T-VEC; Imlygic) led to significant improvement in 1-year recurrence-free survival (RFS) for patients with resectable advanced melanoma compared with surgery alone, a randomized trial showed.1 At 1 year, 33.5% of patients who received preoperative T-VEC plus surgery remained recurrence free, as compared […]

Read the full story

Posted in Melanoma News, Health Professionals, Conferences

Dabrafenib/Trametinib Combo Provides Lasting Control for BRAF V600-Mutant Metastatic Melanoma

Source: OncLive, July 2019 Five years out, one-third of patients with unresectable or metastatic BRAF V600-mutant melanoma remained alive following treatment with dual targeted therapy with dabrafenib (Tafinlar) plus trametinib (Mekinist), and 1 in 5 remained alive without progression, according to an analysis COMBI-d and COMBI-v trials reported at the 2019 ASCO Annual Meeting.1 Pooled data from […]

Read the full story

Posted in Melanoma News, Health Professionals, Conferences

ASCO 2019: T-VEC shows improved survival over cytokine therapy in patients with melanoma

Source: ECancer News, July 2019 Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma at Roswell Park Comprehensive Cancer Center, led research on the immunotherapy T-VEC, or talimogene laherparepvec, to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Dr. Puzanov is senior author […]

Read the full story

Posted in Melanoma News, Health Professionals, Conferences

ASCO 2019: T-VEC shows improved survival over cytokine therapy in patients with melanoma

Source: ECancer News, July 2019 Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma at Roswell Park Comprehensive Cancer Center, led research on the immunotherapy T-VEC, or talimogene laherparepvec, to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Dr. Puzanov is senior author […]

Read the full story

Posted in Melanoma News, Health Professionals, Conferences

2019 Events

Calculate your risk of getting melanoma Sunscreen calculator
Map of body for recording areas of skin causing you concern on your body Target Therapy Finder